Thursday, March 8, 2012

Updated agenda available for optimizing PCI outcomes symposium to be held March 23 in Chicago

Updated agenda available for optimizing PCI outcomes symposium to be held March 23 in Chicago [ Back to EurekAlert! ] Public release date: 7-Mar-2012
[ | E-mail | Share Share ]

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation

Meeting will cover the latest breakthroughs in the percutaneous treatment of coronary artery disease

WHAT & WHY: The agenda for the Optimizing PCI Outcomes: A Vision for 2012 symposium is now available at: http://www.pcioutcomes.com/conference/agenda.html. This evening symposium will feature the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease, including the latest clinical data on current and second-generation drug-eluting stent device-based therapies. Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions.

Presentations will focus on:

  • The Case for Surgery and the Case for PCI In Patients with Complex Coronary Artery Disease
  • The Appropriateness of PCI Procedures
  • Optimizing Pharmacology Before, During, and After PCI
  • Prevention and Treatment of Stent Thrombosis
  • Complex PCI: Technique, Tips, and Tricks

WHEN:
Friday, March 23, 2012
5:30 PM-9:30 PM

WHERE:
Swisstel Chicago
323 East Wacker Drive
Chicago, IL

This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology's Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.

For more information visit: http://www.pcioutcomes.com/

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.

ABOUT CRF

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Updated agenda available for optimizing PCI outcomes symposium to be held March 23 in Chicago [ Back to EurekAlert! ] Public release date: 7-Mar-2012
[ | E-mail | Share Share ]

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation

Meeting will cover the latest breakthroughs in the percutaneous treatment of coronary artery disease

WHAT & WHY: The agenda for the Optimizing PCI Outcomes: A Vision for 2012 symposium is now available at: http://www.pcioutcomes.com/conference/agenda.html. This evening symposium will feature the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease, including the latest clinical data on current and second-generation drug-eluting stent device-based therapies. Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions.

Presentations will focus on:

  • The Case for Surgery and the Case for PCI In Patients with Complex Coronary Artery Disease
  • The Appropriateness of PCI Procedures
  • Optimizing Pharmacology Before, During, and After PCI
  • Prevention and Treatment of Stent Thrombosis
  • Complex PCI: Technique, Tips, and Tricks

WHEN:
Friday, March 23, 2012
5:30 PM-9:30 PM

WHERE:
Swisstel Chicago
323 East Wacker Drive
Chicago, IL

This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology's Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.

For more information visit: http://www.pcioutcomes.com/

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.

ABOUT CRF

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-03/crf-uaa030712.php

houston nutt peter marshall peter marshall zombie boy zombie boy harvard yale joe paterno lung cancer

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)